Evidence map›Paper›PMID 40354100›Full record

ArticleJournal of the American Chemical Society2025

Bridged Boranoanthracenes: Precursors for Free Oxoboranes through Aromatization-Driven Oxidative Extrusion.

Stav Deri, Moran Feller, Shibaram Panda, Batya Blank, Mark A Iron, Yael Diskin-Posner, Liat Avram, Linda J W Shimon, Rakesh Mondal, Samer Gnaim

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stav DeriDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot 7610001, Israel.
Moran FellerDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0001-7436-9183
Shibaram PandaDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot 7610001, Israel.
Batya BlankDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot 7610001, Israel.
Mark A IronDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0001-9774-2358
Yael Diskin-PosnerDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0002-9008-8477
Liat AvramDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0001-6535-3470
Linda J W ShimonDepartment of Chemical Research Support, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0002-7861-9247
Rakesh MondalDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot 7610001, Israel.
Samer GnaimDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot 7610001, Israel.ORCID 0000-0001-9030-4195

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We introduce a novel class of boranobornadiene derivatives, termed boranoanthracene, along with an in-depth study of their structures and reactivities. Using these versatile precursors, we propose a fundamentally novel mechanism for generating free oxoborane species. This pathway enables the formation of aminoxoborane species, which are rarely reported in the literature. The proposed mechanism unfolds via the coordination of an

Identifiers

PMID40354100
PMCPMC12164262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.